Health
Presage Biosciences Advances Groundbreaking CIVO® Clinical Trial for Promising Cancer Drug Candidate
According to Biospace, Seattle-based biotech firm Presage Biosciences has received FDA approval to proceed with a groundbreaking study involving the pre-GMP drug candidate PBA-0405,...